What is the address of HUBIMEDIC?

The registered office of HUBIMEDIC is located at Rue du Bief 22, 4652 Herve.

Is HUBIMEDIC still active?

Yes. According to the CBE (16 September 2026) HUBIMEDIC is active, legal situation “Normale toestand”, started on 6 January 2014.

Is HUBIMEDIC registered on Peppol?

Yes, HUBIMEDIC is registered on the Peppol network with ID 0208:0543795361.

What is the enterprise number of HUBIMEDIC?

The enterprise number of HUBIMEDIC is BE0543795361.

When was HUBIMEDIC founded?

HUBIMEDIC was founded on 6 January 2014.

Who are the directors of HUBIMEDIC?

According to the 2025 annual accounts, the directors of HUBIMEDIC are: GREGORY HUBIN.

Is HUBIMEDIC a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 January 2014; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did HUBIMEDIC make in 2025?

HUBIMEDIC posted a profit after taxes of € 162,334 in financial year 2025.

What is the revenue of HUBIMEDIC?

As a small company, HUBIMEDIC is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 359,220.

HUBIMEDIC (Private Limited) - Herve - BE0543795361

Dossier HUBIMEDIC, printed on 16 September 2026 from databakkes.be/en/0543795361/hubimedic. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2024.

Financials

Financial year 2025

HUBIMEDIC from Herve, company number BE0543795361, closed financial year 2025 with a result of € 162,334 after tax. For that financial year HUBIMEDIC recorded a gross margin of € 359,220 and equity of € 499,506. Compared with financial year 2024, the result moved from € 107,148 to € 162,334. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on January 30, 2026.

What it is worth Growing

€ 499,506

▲ 31% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 162,334

▲ 52% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 442,685

▼ 5% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 45,000 paid out

28 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 9,592

▲ 57% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 17 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.3 million

€ 72,297 is repaid this year. At this pace the long-term loan is gone in ≈ 17 years.

Owed to suppliers

€ 21,105

▲ € 17,420 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 18,488

▲ 188% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 172,056 Gross margin 2022: € 172,056 First fiscal year in the series	€ 291,191 Gross margin 2023: € 291,191 ▲ 69% vs 2022 (€ 172,056) Favourable step	€ 302,234 Gross margin 2024: € 302,234 ▲ 4% vs 2023 (€ 291,191) Favourable step	€ 359,220 Gross margin 2025: € 359,220 ▲ 19% vs 2024 (€ 302,234) Favourable step	▲ 19%
Profit after taxes	€ 49,155 Profit after taxes 2022: € 49,155 First fiscal year in the series	€ 110,162 Profit after taxes 2023: € 110,162 ▲ 124% vs 2022 (€ 49,155) Favourable step	€ 107,148 Profit after taxes 2024: € 107,148 ▼ 3% vs 2023 (€ 110,162) Unfavourable step	€ 162,334 Profit after taxes 2025: € 162,334 ▲ 52% vs 2024 (€ 107,148) Favourable step	▲ 52%
Equity	€ 214,862 Equity 2022: € 214,862 First fiscal year in the series	€ 325,024 Equity 2023: € 325,024 ▲ 51% vs 2022 (€ 214,862) Favourable step	€ 382,172 Equity 2024: € 382,172 ▲ 18% vs 2023 (€ 325,024) Favourable step	€ 499,506 Equity 2025: € 499,506 ▲ 31% vs 2024 (€ 382,172) Favourable step	▲ 31%
Total debts	€ 353,739 Total debts 2022: € 353,739 First fiscal year in the series	€ 959,982 Total debts 2023: € 959,982 ▲ 171% vs 2022 (€ 353,739) Unfavourable step	€ 1,504,847 Total debts 2024: € 1,504,847 ▲ 57% vs 2023 (€ 959,982) Unfavourable step	€ 1,515,303 Total debts 2025: € 1,515,303 ▲ 1% vs 2024 (€ 1,504,847) Unfavourable step	▲ 1%
Cash	€ 159,534 Cash 2022: € 159,534 First fiscal year in the series	€ 223,313 Cash 2023: € 223,313 ▲ 40% vs 2022 (€ 159,534) Favourable step	€ 464,183 Cash 2024: € 464,183 ▲ 108% vs 2023 (€ 223,313) Favourable step	€ 442,685 Cash 2025: € 442,685 ▼ 5% vs 2024 (€ 464,183) Unfavourable step	▼ 5%
Land & buildings	€ 277,213 Land & buildings 2022: € 277,213 First fiscal year in the series	€ 913,473 Land & buildings 2023: € 913,473 ▲ 230% vs 2022 (€ 277,213) Unchanged	€ 1,292,659 Land & buildings 2024: € 1,292,659 ▲ 42% vs 2023 (€ 913,473) Unchanged	€ 1,386,628 Land & buildings 2025: € 1,386,628 ▲ 7% vs 2024 (€ 1,292,659) Unchanged	▲ 7%
Retained profit	€ 202,462 Retained profit 2022: € 202,462 First fiscal year in the series	€ 312,624 Retained profit 2023: € 312,624 ▲ 54% vs 2022 (€ 202,462) Favourable step	€ 369,772 Retained profit 2024: € 369,772 ▲ 18% vs 2023 (€ 312,624) Favourable step	€ 487,106 Retained profit 2025: € 487,106 ▲ 32% vs 2024 (€ 369,772) Favourable step	▲ 32%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 50,000 Dividend 2024: € 50,000 Unchanged (€ 0) Unchanged	€ 45,000 Dividend 2025: € 45,000 ▼ 10% vs 2024 (€ 50,000) Unchanged	▼ 10%
Bank debt	€ 212,017 Bank debt 2022: € 212,017 First fiscal year in the series	€ 767,555 Bank debt 2023: € 767,555 ▲ 262% vs 2022 (€ 212,017) Unfavourable step	€ 1,255,686 Bank debt 2024: € 1,255,686 ▲ 64% vs 2023 (€ 767,555) Unfavourable step	€ 1,251,390 Bank debt 2025: € 1,251,390 Unchanged (€ 1,255,686) Favourable step
Balance sheet total	€ 568,601 Balance sheet total 2022: € 568,601 First fiscal year in the series	€ 1,285,006 Balance sheet total 2023: € 1,285,006 ▲ 126% vs 2022 (€ 568,601) Unchanged	€ 1,887,019 Balance sheet total 2024: € 1,887,019 ▲ 47% vs 2023 (€ 1,285,006) Unchanged	€ 2,014,809 Balance sheet total 2025: € 2,014,809 ▲ 7% vs 2024 (€ 1,887,019) Unchanged	▲ 7%

Key figures of HUBIMEDIC, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to HUBIMEDIC?

What happened at HUBIMEDIC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 30, 2026 New annual accounts for financial year 2025: profit of € 162,334 (▲ 52% vs 2024). Source: NBB ↗
Feb 20, 2014 New establishment in Spa. KBO
Feb 20, 2014 New establishment in Herve. KBO
Jan 6, 2014 Start of the company according to the CBE. KBO

In short

From € 49,155 profit in 2022 to € 162,334 profit in 2025.

Paid € 133,815 in corporate taxes since 2022.

Best year ever: 2025, with € 162,334 profit.

Paid out € 95,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at HUBIMEDIC? We notify you, reason included.

Follow HUBIMEDIC

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

GREGORY HUBIN

HUBIMEDIC

MEDISPA

Behind HUBIMEDIC is GREGORY HUBIN. GREGORY HUBIN is also behind MEDISPA.

See the full network in the app

Directors

According to the 2025 annual accounts

GREGORY HUBIN

Director

Also active at: MEDISPA

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Bief 22

4652 Herve

2.226.932.433

Avenue Dr. Pierre Gaspar 1

4900 Spa

Active since 20 February 2014

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0543.795.361
VAT number: BE 0543.795.361
Registered office: Rue du Bief 22, 4652 Herve
Names & denominations: HUBIMEDIC
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 January 2014
Peppol: Active · Active since 23 Apr 2026

View on CBE Public ↗ Annual accounts (NBB) ↗